◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Terumo Corporation (4543)
来自官方财务报表的收入、利润与现金流历史。
Healthcare · 华尔街（美国） · 最近更新： 2026-10-02
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies.
关键数据
- 市值: JPY 3.31 trillion
- 收入（截至 2026-03-31 财年）: JPY 1.13T
- 净利润: JPY 135.9B
- 毛利率: 52.5%
- 净利率: 12.0%
查看交互式图表与完整报表 →
估值模型 (DCF) →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|
| 总收入 | JPY 1.13T | JPY 1.04T | JPY 921.9B | JPY 820.2B | — |
| 毛利 | JPY 594.7B | JPY 560.7B | JPY 479.2B | JPY 417.4B | — |
| 营业利润（EBIT） | JPY 176.3B | JPY 157.7B | JPY 140.1B | JPY 117.3B | — |
| 净利 | JPY 135.9B | JPY 117.0B | JPY 106.4B | JPY 89.3B | — |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 4543 交互式查看器。 /companies/us/4543
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.